Heres a quick comparison: Ozempic : Once-weekly injection, GLP-1 receptor agonist, supports both blood sugar and weight Saxe n da : Daily injection, similar mechanism, often more expensive over time Metformin : Oral tablet, lower cost, primarily for glucose control A study highlighted by Mayo Clinic shows that Ozempic users lost an average of 5 to 10 percent of body weight within 6 months when paired with a healthy diet and lifestyle
Skip snacks if: You're meeting protein targets with three meals You're truly not hungry (don't force it) You're within 2-3 hours of your next meal Eating makes you feel nauseated You're in the first few days post-injection when appetite is lowest The goal is adequate nutritionnot eating for eating's sake
I think this will help decrease the concern and the alarm in patients on GLP-1s undergoing these procedures. Schulman noted, however, that the bigger question is what happens with urgent or emergent cases
They discovered that exposure to GLP-1 receptor agonists was linked with heightened pre-term birth risk when prescribed for diabetes treatment, but not amongst those using the medication for weight management
[Accessed on February 7, 2026] Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen
Obesity brings with it many complications, including an increased risk of cardiovascular disease, type 2 diabetes mellitus and stroke